Analysis of risk evaluation and mitigation strategies for te

In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures.

Related Keywords

Heidi Zakoul , Supreme Court , Drug Administration , Creative Commons Attribution License , Editorial Board , Teratogen Information System , Female Contraception , Medical Risk Factors , Pregnancy , Contraceptive Therapy , Contraception , Drug Therapy , Miscarriage ,